These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16170191)

  • 1. Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer.
    Atkins CD
    J Clin Oncol; 2005 Sep; 23(27):6799-800; author reply 6800. PubMed ID: 16170191
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
    J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.
    Dooms C; Vansteenkiste J
    J Thorac Oncol; 2010 May; 5(5):583-4. PubMed ID: 20421763
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non small cell lung carcinoma - evaluation of tumor heterogeneity using CT texture analysis].
    Manych M
    Rofo; 2012 Nov; 184(11):978. PubMed ID: 23104480
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.
    Thie JA
    J Nucl Med; 2006 Nov; 47(11):1901-2; author reply 1902. PubMed ID: 17079825
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
    Downey RJ; Akhurst T; Gonen M; Vincent A; Bains MS; Larson S; Rusch V
    J Clin Oncol; 2004 Aug; 22(16):3255-60. PubMed ID: 15310769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
    Akhurst T
    J Surg Oncol; 2006 Dec; 94(7):547-8. PubMed ID: 17111390
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    Hoang JK; Hoagland LF; Coleman RE; Coan AD; Herndon JE; Patz EF
    J Clin Oncol; 2008 Mar; 26(9):1459-64. PubMed ID: 18349396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
    Vansteenkiste JF
    Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G
    J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Can positron-emission tomography modify the management of non-small-cell lung cancer?].
    Ninane V
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S5-7. PubMed ID: 16719146
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
    Buck AK; Glatting G; Reske SN
    J Nucl Med; 2004 Aug; 45(8):1274-6. PubMed ID: 15299047
    [No Abstract]   [Full Text] [Related]  

  • 15. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era.
    De Pas TM; de Braud F; Catalano G; Putzu C; Veronesi G; Leo F; Solli PG; Brambilla D; Paganelli G; Spaggiari L
    Ann Thorac Surg; 2007 Jan; 83(1):231-4. PubMed ID: 17184669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
    Kong FM; Frey KA; Quint LE; Ten Haken RK; Hayman JA; Kessler M; Chetty IJ; Normolle D; Eisbruch A; Lawrence TS
    J Clin Oncol; 2007 Jul; 25(21):3116-23. PubMed ID: 17634490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    Hoekstra CJ; Stroobants SG; Smit EF; Vansteenkiste J; van Tinteren H; Postmus PE; Golding RP; Biesma B; Schramel FJ; van Zandwijk N; Lammertsma AA; Hoekstra OS
    J Clin Oncol; 2005 Nov; 23(33):8362-70. PubMed ID: 16293866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
    Laking G; Price P
    Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
    [No Abstract]   [Full Text] [Related]  

  • 19. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.